Comprehensive Electrolyte Panel Na · K · Mg · Ca · PO₄ — Triage, Sequencing & Interplay · v2.1
Workflow: Sodium, potassium, magnesium, calcium, and phosphate commonly derange together (diuretics, DKA, refeeding, tumour lysis, CKD). This tool interprets the whole panel at once, recognises combined patterns, flags dangerous interactions, and generates a sequenced correction plan. Enter at least one value; enter more for full interplay analysis.
1. The Electrolytes
2. Sodium Kinetics (for glucose correction & Adrogué-Madias)
3. Shared Clinical Context
4. Common Shared Causes & Modifiers
Why Correct in Sequence? The Core Principle

When multiple electrolytes are deranged, the order of correction determines success:

  • Immediate cardiac/neurological threats first. Severe hyperkalaemia with ECG changes (calcium), Torsades (magnesium), severe symptomatic hyponatraemia (hypertonic saline), and symptomatic hypocalcaemia (IV calcium) override metabolic sequencing.
  • Magnesium is the master electrolyte. Both hypokalaemia and hypocalcaemia are refractory until magnesium is replaced.
  • Then potassium (with magnesium alongside), then calcium (caution if phosphate high), then phosphate, then sodium (potassium replacement itself raises sodium).
Sodium Correction Factor for Hyperglycaemia

This tool uses the Katz/Hillier hybrid: corrected Na = measured Na + 1.6 × ((glucose − 100)/100) for glucose up to 400 mg/dL, then 2.4 per 100 mg/dL for the increment above 400. Applying the higher 2.4 factor to the entire glucose elevation (a common coding error) overestimates corrected sodium in severe HHS and can lead to inappropriate withholding of free water. The relationship is non-linear and steeper at very high glucose, which the hybrid captures.

Note: there is no single universally-mandated factor - the classic Katz value is 1.6, Hillier (1999) argued 2.4 fits better across the range, and the piecewise hybrid used here is a pragmatic middle ground.

The Ca × PO₄ Product Uses TOTAL (Measured) Calcium

The calcium-phosphate solubility product and its > 55 mg²/dL² threshold (KDOQI) are calibrated to total (measured) calcium × phosphate - not albumin-corrected calcium. Using corrected calcium would falsely inflate the product in hypoalbuminaemic patients and could wrongly block necessary calcium replacement. This tool therefore grades hypo/hypercalcaemia severity on corrected calcium (correct for grading) but computes the Ca×PO₄ product on measured calcium (correct for the product).

The DKA Potassium Rule (fires independent of K entry)

Total body potassium is depleted in every DKA patient, even when serum K looks normal or high. Insulin drives K intracellularly and can precipitate fatal hypokalaemia. Do not start insulin until K is known and confirmed above 3.3 mEq/L. This tool surfaces the DKA potassium rule whenever DKA is flagged, whether or not a potassium value has been entered.

The Magnesium Gate & The Potassium Trap

Magnesium gate: low Mg drives renal K wasting (ROMK) and impairs PTH, so both hypokalaemia and hypocalcaemia are refractory until Mg is replaced. Potassium trap: replacing K raises serum Na (~1 mEq Na per mEq KCl); in a hyponatraemic patient this can overshoot the safe sodium limit and cause osmotic demyelination - count K replacement against the 24h sodium budget.

Recognisable Combined Patterns
PatternSignatureKey Action
Refeeding SyndromeK↓ Mg↓ PO₄↓Replace all three. Thiamine before glucose. Slow Na correction (high ODS risk).
Tumour Lysis SyndromeK↑ PO₄↑ Ca↓ (+ high urate, AKI)Hydration, rasburicase. Treat hyperK. Don't give calcium for asymptomatic hypocalcaemia.
CKD Mineral-Bone DiseaseCa↓ PO₄↑Phosphate binders, calcitriol. Correct phosphate before calcium.
Diuretic DepletionNa↓ K↓ Mg↓Hold diuretic. Mg first, then K. Volume restore for Na.
DKATotal body K, Mg, PO₄ depleted; pseudo-hypoNaNo insulin if K < 3.3. Replace K/Mg/PO₄. Correct glucose - Na follows.
Renal RetentionK↑ Mg↑ PO₄↑ (oliguric)Membrane stabilisation if hyperK with ECG changes. Dialysis is definitive.
Adrogué-Madias Equation (replaces deficit-replacement)

ΔNa per 1 L infusate = (Infusate Na − Serum Na) / (Total Body Water + 1). This estimates how much 1 litre of a given fluid will move the serum sodium, and is preferred over closed-system "deficit" formulas (which ignore renal free water clearance and routinely cause ODS). This panel shows the ΔNa figure as a quick reference when sodium is low and weight is entered; for the full tier-gated infusion schedule, monitoring timeline, and overcorrection-rescue protocol, open the dedicated Acute Hyponatraemia Protocol.

Reference Ranges & Severity Bands
ElectrolyteNormalLow (severe)High (severe)
Sodium135 - 145 mEq/L< 120 (severe), < 110 (critical)> 160 mEq/L
Potassium3.5 - 5.0 mEq/L< 2.5 mEq/L≥ 6.5 mEq/L
Magnesium1.8 - 2.4 mg/dL< 1.0 mg/dL> 7.0 mg/dL
Calcium (corrected)8.5 - 10.5 mg/dL< 6.0 mg/dL> 14 mg/dL
Phosphate2.5 - 4.5 mg/dL< 1.0 mg/dL> 7.0 mg/dL

Corrected Ca = measured Ca + 0.8 × (4.0 − albumin), used for severity grading. Mg: 1.8 to 2.4 mg/dL ≈ 0.75 to 1.0 mmol/L (divide mg/dL by 2.43). Phosphate: divide mg/dL by 3.1 for mmol/L.

Abbreviations: Na⁺ (Sodium) · K⁺ (Potassium) · Mg (Magnesium) · Ca (Calcium) · PO₄ (Phosphate) · TBW (Total Body Water) · ROMK (Renal Outer Medullary Potassium channel) · ODS (Osmotic Demyelination Syndrome) · DKA (Diabetic Ketoacidosis) · HHS (Hyperosmolar Hyperglycaemic State) · TLS (Tumour Lysis Syndrome) · CKD-MBD (CKD Mineral-Bone Disease) · TdP (Torsades de Pointes) · PTH (Parathyroid Hormone)
Algorithm References & Evidence Base
  1. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106(4):399-403.
  2. Katz MA. Hyperglycemia-induced hyponatremia. N Engl J Med. 1973;289(16):843-844.
  3. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-1589.
  4. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649-2652.
  5. Mehanna HM, Moledina J, Travis J. Refeeding syndrome. BMJ. 2008;336(7659):1495-1498.
  6. Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844-1854.
  7. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in CKD. Am J Kidney Dis. 2003;42(4 Suppl 3):S1-S201.
How to Cite This Tool

AMA Style:
Umakanth S. Comprehensive Electrolyte Panel. MEDiscuss. Published 2026. Accessed .

Vancouver Style:
Umakanth S. Comprehensive Electrolyte Panel [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:

Category Therapeutic Pathways & Algorithms
Specialties Internal Medicine, Nephrology, Critical Care, Emergency Medicine
Status New Pathway